Original Research J Clin Psychiatry June 2026

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure

Full Article Read the complete peer-reviewed article in J Clin Psychiatry. Clinical Summary After mass trauma, patients often present with severe insomnia, anxiety, and hyperarousal, yet clinicians are warned that benzodiazepines given early may raise later PTSD risk. This study directly addresses that bedside dilemma by separating short-term posttrauma use from ongoing use in a large real-world cohort of newly prescribed patients. FAQ Does filling a benzodiazepine prescription after trauma increase the risk of developing PTSD? 9 questions
Key Takeaways In the main 3-group analysis, 12-month PTSD risk was similar whether prescriptions were not filled, filled within ≤7 days, or filled in 8–30 days: 5.2%, 4.7%, and 5.0%, respectively, with overlapping Kaplan-Meier curves (log-rank χ2 =0.8; P =.7). 6 takeaways Clinical Guide How should clinicians interpret a new benzodiazepine prescription fill after mass trauma when estimating subsequent PTSD risk? 5 steps Clinical Guide How should clinicians use posttrauma benzodiazepine refill behavior to identify patients who need reassessment for PTSD and unresolved distress? 5 steps
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe